• Explore /
  • Poster
  • / Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Comparing the prognostic and predictive utility of serum thymidine kinase 1 and CA 15-3 in patients with hormone receptor positive metastatic breast cancer starting first-line endocrine therapy in SWOG S0226.

Abstract Poster

Authors

Erin Cobain

Erin Frances Cobain

University of Michigan, Ann Arbor, MI

Erin Frances Cobain , William E. Barlow , Costanza Paoletti , Mattias Bergqvist , Amy Williams , Hanna Ritzen , Rita S. Mehta , Julie R. Gralow , Gabriel N. Hortobagyi , Kathy S. Albain , Lajos Pusztai , Priyanka Sharma , Andrew K. Godwin , Alastair Mark Thompson , Daniel F. Hayes , James M. Rae

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Hormone Receptor-Positive

Clinical Trial Registration Number

NCT00075764

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 1076)

DOI

10.1200/JCO.2023.41.16_suppl.1076

Abstract #

1076

Poster Bd #

297

Abstract Disclosures

Similar Posters

First Author: Rinath Jeselsohn

First Author: Oana Cristina Danciu

First Author: Suhail M. Ali

First Author: Joohyuk Sohn